(Reuters) -R1 RCM said on Thursday private-equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R) would acquire the healthcare technology company in a deal that values it at $8.9 ...
The deal, expected to close by the end of the year, was unanimously approved by a special committee formed by R1 in March to consider strategic alternatives. The acquisition comes after R1, which ...
The RealClearMarkets/TIPP Economic Optimism Index, a key gauge of consumer sentiment, fell from 52.0 in February to 49.8 in March, a 4.2% drop. After hitting a 40-month high of 54.0 in December, it ...
The December reading of 47.9 marks a solid 9% monthly gain. Consumer sentiment improved in December, as the RealClearMarkets/TIPP Economic Optimism Index, the first monthly read on U.S. consumer ...
As Dallas-based Tenet Healthcare sold off hospitals in 2024, its Conifer subsidiary struck contracts to provide revenue cycle management services for the offloaded hospitals. Conifer also extended an ...
R1 RCM, a company that provides revenue cycle and billing services to hospitals, will be acquired for $8.9 billion and taken private. Investment funds tied to TowerBrook Capital Partners and Clayton, ...
From Optum launching a new AI-powered revenue cycle platform to a Florida hospital striking an RCM partnership with Ensemble, here are eight RCM updates that Becker’s reported in May: 2. R1 RCM ...
Explore R1 RCM stock price history with detailed daily historical prices, including open, high, low, and volume data. Review stock chart history to analyze past trends and find the highest R1 RCM ...
RCM Technologies experienced vigorous growth during COVID-19, faced setbacks in late 2022 and early 2023, but began recovering in the second half of 2023. Despite rising revenues in the third quarter, ...
RCM Technologies, Inc. (RCMT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...
Aug 1 (Reuters) - R1 RCM (RCM.O), opens new tab said on Thursday private-equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R) would acquire the healthcare technology company in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results